✦ LIBER ✦

Efficacy of the Protease Inhibitor BI 201335, Polymerase Inhibitor BI 207127, and Ribavirin in Patients With Chronic HCV Infection

✍ Scribed by Stefan Zeuzem; Tarik Asselah; Peter Angus; Jean–Pierre Zarski; Dominique Larrey; Beat Müllhaupt; Ed Gane; Marcus Schuchmann; Ansgar Lohse; Stanislas Pol; Jean–Pierre Bronowicki; Stuart Roberts; Keikawus Arasteh; Fabien Zoulim; Markus Heim; Jerry O. Stern; George Kukolj; Gerhard Nehmiz; Carla Haefner; Wulf Otto Boecher

Book ID: 119761998
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 915 KB
Volume: 141
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2011.08.051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exam 2: Efficacy of the Protease Inhibit

Exam 2: Efficacy of the Protease Inhibitor BI 201335, Polymerase Inhibitor BI 207127, and Ribavirin in Patients With Chronic HCV Infection

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Potency, safety, and pharmacokinetics of

Potency, safety, and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection

✍ Michael P. Manns; Marc Bourlière; Yves Benhamou; Stanislas Pol; Maurizio Bonacin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 767 KB

954 BI 201335, A POTENT HCV NS3 PROTEASE

954 BI 201335, A POTENT HCV NS3 PROTEASE INHIBITOR, IN TREATMENT-NAIVE AND -EXPERIENCED CHRONIC HCV GENOTYPE-1 INFECTION: GENOTYPIC AND PHENOTYPIC ANALYSIS OF THE NS3 PROTEASE DOMAIN

✍ G. Kukolj; Y. Benhamou; M.P. Manns; M. Bourlière; S. Pol; M. Schuchmann; M. Cart 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB

101 SVR4 AND SVR12 WITH AN INTERFERON-FR

101 SVR4 AND SVR12 WITH AN INTERFERON-FREE REGIMEN OF BI201335 AND BI207127, +/- RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC GENOTYPE-1 HCV INFECTION: INTERIM RESULTS OF SOUND-C2

✍ S. Zeuzem; V. Soriano; T. Asselah; J.-P. Bronowicki; A. Lohse; B. Müllhaupt; M. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 158 KB

2007 4 WEEK THERAPY WITH THE NON-NUCLEOS

2007 4 WEEK THERAPY WITH THE NON-NUCLEOSIDIC POLYMERASE INHIBITOR BI207127 IN COMBINATION WITH PEGINTERFERON-ALFA2A AND RIBAVIRIN IN TREATMENT NAIVE AND TREATMENT EXPERIENCED CHRONIC HCV GT1 PATIENTS

✍ Larrey, D.; Lohse, A.; de Ledinghen, V.; Trepo, C.; Gerlach, T.; Zarski, J.-P.; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 54 KB

1420 THE EFFICACY AND SAFETY OF THE INTE

1420 THE EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF BI201335 AND BI207127 IN GENOTYPE 1 HCV PATIENTS WITH CIRRHOSIS - INTERIM ANALYSIS FROM SOUND-C2

✍ Soriano, V.; Gane, E.; Angus, P.; Stickel, F.; Bronowicki, J.-P.; Roberts, S.; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 59 KB